{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:37:42Z","timestamp":1762324662322,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.vaccine.2020.02.012","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T09:17:44Z","timestamp":1582190264000},"page":"2859-2869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Higher mass meningococcal group C-tetanus toxoid vaccines conjugated with carbodiimide correlate with greater immunogenicity"],"prefix":"10.1016","volume":"38","author":[{"given":"Kay","family":"Lockyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagwati","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Stebbings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy P.","family":"Derrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bolgiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2020.02.012_b0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1073\/pnas.1816401115","article-title":"Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines","volume":"116","author":"Sun","year":"2019","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.012_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"On the mechanism of conjugate vaccines","volume":"116","author":"Rappuoli","year":"2019","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2020.02.012_b0015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","article-title":"Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/4: contribution and experiences of the meningococcal reference unit","volume":"55","author":"Gray","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2020.02.012_b0020","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1016\/j.vaccine.2012.03.011","article-title":"Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines","volume":"30","author":"Ladhani","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.02.012_b0025","doi-asserted-by":"crossref","first-page":"A97","DOI":"10.1016\/j.vaccine.2007.04.049","article-title":"The meningitis vaccine project","volume":"25","author":"LaForce","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2020.02.012_b0030","doi-asserted-by":"crossref","first-page":"S396","DOI":"10.1093\/cid\/civ594","article-title":"The evolution of the meningitis vaccine project","volume":"61","author":"Tiffay","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5,","key":"10.1016\/j.vaccine.2020.02.012_b0035","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/IAI.66.5.2186-2192.1998","article-title":"Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy","volume":"66","author":"Wessels","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.012_b0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1086\/514063","article-title":"Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines","volume":"176","author":"Daum","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.012_b0045","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.4049\/jimmunol.146.12.4308","article-title":"A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice","volume":"146","author":"Peeters","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.02.012_b0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0264-410X(96)00148-X","article-title":"The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity","volume":"15","author":"Laferriere","year":"1997","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2020.02.012_b0055","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/CVI.00122-06","article-title":"Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity","volume":"13","author":"Michon","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"23","key":"10.1016\/j.vaccine.2020.02.012_b0060","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.vaccine.2015.04.031","article-title":"Development and characterisation of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths","volume":"33","author":"Rana","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.02.012_b0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0928-8244(03)00346-8","article-title":"Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide \u2013 P64K protein conjugates","volume":"40","author":"Carmenate","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2020.02.012_b0070","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi","volume":"29","author":"Micoli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.012_b0075","unstructured":"Tontini M. Characterization of carbohydrate based vaccines. PhD Thesis. Universite de Cergy Pontoise, 2012 https:\/\/tel.archives-ouvertes.fr\/tel-00825838\/document [Accessed 25 Oct 2019]."},{"key":"10.1016\/j.vaccine.2020.02.012_b0080","doi-asserted-by":"crossref","unstructured":"Arcuri, M., Di Benedetto, R., Cunningham, A.F., Saul, A., MacLennan, C.A., Micoli, F. The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi. PLoS one, (2017), 12 (12), (2017), 1-14. doi: 10.1371\/journal.pone.0189100.","DOI":"10.1371\/journal.pone.0189100"},{"key":"10.1016\/j.vaccine.2020.02.012_b0085","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4049\/jimmunol.137.4.1181","article-title":"Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.","volume":"137","author":"Anderson","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.02.012_b0090","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.142.7.2464","article-title":"Effect of oligosaccharide chain length, exposed terminal groups, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b antigen unterminally coupled to the diphtheria protein CRM197","volume":"142","author":"Anderson","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.02.012_b0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/BA20020066","article-title":"Evaluation of meningococcal C oligosaccharide conjugate vaccines by size-exclusion chromatography\/multi-angle laser light scattering","volume":"26","author":"Jumel","year":"2002","journal-title":"Biotech Appl Biochem"},{"key":"10.1016\/j.vaccine.2020.02.012_b0100","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2015.01.046","article-title":"Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines","volume":"33","author":"Lockyer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.012_b0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biologicals.2012.03.003","article-title":"Evaluation of a candidate international standard for meningococcal group C polysaccharide","volume":"40","author":"Vipond","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2020.02.012_b0110","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/iai.65.6.2088-2093.1997","article-title":"Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker","volume":"65","author":"Kossaczka","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.012_b0115","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/j.vaccine.2017.03.066","article-title":"Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197 DT and TT glycoconjugates","volume":"35","author":"Beresford","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.012_b0120","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1016\/j.vaccine.2019.05.050","article-title":"O-acetylation of typhoid capsular polysaccharide confers polysaccharide rigidity and immunodominance by masking additional epitopes","volume":"37","author":"Hitri","year":"2019","journal-title":"Vaccine"},{"issue":"6229","key":"10.1016\/j.vaccine.2020.02.012_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/340167a0","article-title":"Stable cell membrane labelling","volume":"340","author":"Horan","year":"1989","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.012_b0130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1097-0320(19990801)36:4<312::AID-CYTO5>3.0.CO;2-V","article-title":"Phototoxicity of the fluorescent membrane dyes PKH2 and PKH26 on the human hematopoietic KG1a progenitor cell line","volume":"36","author":"Oh","year":"1999","journal-title":"Cytometry"},{"issue":"6","key":"10.1016\/j.vaccine.2020.02.012_b0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1440-1711.1999.00877.x","article-title":"Fluorescent dyes for lymphocyte migration and proliferation studies","volume":"77","author":"Parish","year":"1999","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2020.02.012_b0140","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2010.07.005","article-title":"Immunogenicity and thermal stability of a combined vaccine against Haemophilus influenzae type b and Neisseria meningitidis serogroup C diseases","volume":"28","author":"Saydam","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.012_b0145","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/iai.60.2.584-589.1992","article-title":"Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate","volume":"60","author":"Fattom","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.012_b0150","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10719-011-9344-3","article-title":"Experimental design to optimize an Haemophilus influenzae type b conjugate vaccine","volume":"28","author":"Laferriere","year":"2011","journal-title":"Glycoconj J"},{"key":"10.1016\/j.vaccine.2020.02.012_b0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/bip.1978.360170202","article-title":"Characterization of group C meningococcal polysaccharide by light-scattering spectroscopy. III. Determination of molecular weight, radius of gyration, and translational diffusional coefficient","volume":"17","author":"Tsunashima","year":"1978","journal-title":"Biopolymers"},{"key":"10.1016\/j.vaccine.2020.02.012_b0160","doi-asserted-by":"crossref","first-page":"35588","DOI":"10.1038\/srep35588","article-title":"Solution conformation and flexibility of capsular polysaccharides from Neisseria meningitidis and glycoconjugates with the tetanus toxoid protein","volume":"6","author":"Abdelhameed","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.02.012_b0165","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.carbpol.2012.07.032","article-title":"An asymmetric and slightly dimerized structure for the tetanus toxoid protein used in glycoconjugate vaccines","volume":"90","author":"Abdelhameed","year":"2012","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.vaccine.2020.02.012_b0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jmb.2006.09.050","article-title":"The HC fragment of tetanus toxin forms stable, concentration-dependent dimers via an intermolecular disulphide bond","volume":"365","author":"Qazi","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2020.02.012_b0175","doi-asserted-by":"crossref","unstructured":"Berti, F., Multivalent meningococcal conjugate vaccines: chemical conjugation strategies used for the preparation of vaccines licensed or in clinical trials. In Carbohydrate-based vaccines: From concept to clinic, K Prasad (Ed.), American Chemical Society, 2018, Washington, D.C. doi: 10.1021\/bk-2018-1290.ch006.","DOI":"10.1021\/bk-2018-1290.ch006"},{"key":"10.1016\/j.vaccine.2020.02.012_b0180","doi-asserted-by":"crossref","unstructured":"Hennessey, J.P., Jr, Costantino, P., Talaga, P., Beurret, M., Ravenscroft, N., Lessons learned and future challenges in the design and manufacture of glycoconjugate vaccines. In Carbohydrate-Based Vaccines: From Concept to Clinic, A.K. Prasad (ed.), ACS Symposium Series; American Chemical Society: Washington, D.C., 2018.","DOI":"10.1021\/bk-2018-1290.ch013"},{"key":"10.1016\/j.vaccine.2020.02.012_b0185","unstructured":"World Health Organization, Recommendations for the production and control of meningococcal group C conjugate vaccines. WHO Technical report, Series no. 924, 2004, Geneva. https:\/\/www.who.int\/biologicals\/publications\/trs\/areas\/vaccines\/meningococcal\/Annex%203%20(90-94)TRS926meningC2003.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2020.02.012_b0190","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.vaccine.2006.11.029","article-title":"New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization","volume":"25","author":"Cuello","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.012_b0195","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1128\/IAI.71.9.5115-5120.2003","article-title":"Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice","volume":"71","author":"Jin","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.012_b0200","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0264-410X(98)00475-7","article-title":"IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines","volume":"17","author":"Soininen","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.012_b0205","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.02.012_b0210","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","article-title":"Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C","volume":"10","author":"Costantino","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.012_b0215","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0264-410X(98)00348-X","article-title":"Size fractionation of bacterial polysaccharides for their use in conjugate vaccines","volume":"17","author":"Costantino","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.012_b0220","doi-asserted-by":"crossref","unstructured":"Manzi, A.E., Higa, H.H., Diaz, S., Varki, A., Intramolecular self-cleavage of polysialic acids. J Biol Chem, 269, (1994), pp. 23617-23624. http:\/\/www.jbc.org\/content\/269\/38\/23617.full.pdf [Accessed 25 Oct 2019].","DOI":"10.1016\/S0021-9258(17)31560-0"},{"key":"10.1016\/j.vaccine.2020.02.012_b0225","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/abio.1997.2225","article-title":"Separation of oligo\/polymers of 5-N-acetylneuraminic acid, 5-N-glycolylneuraminic acid, and 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid by high-performance anion-exchange chromatography with pulsed amperometric detector","volume":"250","author":"Zhang","year":"1997","journal-title":"Anal Biochem"},{"year":"2018","series-title":"An analysis of the relationship between size and the immune response of glyconjugate vaccines","author":"Lockyer","key":"10.1016\/j.vaccine.2020.02.012_b0230"},{"key":"10.1016\/j.vaccine.2020.02.012_b0235","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.vaccine.2009.03.064","article-title":"Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM(197) conjugate vaccine co-localizes with MHC II on the antigen processing cell surface","volume":"27","author":"Lai","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.012_b0240","doi-asserted-by":"crossref","unstructured":"Ho, M.M., Mawas, F., Bolgiano, B., Lemercinier, X., Crane, D.T., Huskisson,R., et al. Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines. Vaccine, 20 (29\u201330) (2002), pp. 3509-3522. doi: 10.1016\/S0264-410X(02)00342-0.","DOI":"10.1016\/S0264-410X(02)00342-0"},{"key":"10.1016\/j.vaccine.2020.02.012_b0245","doi-asserted-by":"crossref","unstructured":"Bastos, R.C., Correa, M.B., De Souza, I.M., Da Silva, M.N., Da Silva Gomes Pereira, D., Martins, F. O., Da Silva Faria, C., Ano Bom, A. P. D., De Lourdes Leal, M., Jessouroun, E, Da Silva J.G. JR., De Andrade Medronho, R., Da Silveira, I., Brazilian meningococcal C conjugate vaccine: physiochemical immunological and thermal stability characteristics. Glycoconj J., 35, (2018), pp. 3-13. doi: 10.1007\/s10719-017-9787-2.","DOI":"10.1007\/s10719-017-9787-2"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:41:48Z","timestamp":1759401708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20301857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":49,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0264410X20301857"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher mass meningococcal group C-tetanus toxoid vaccines conjugated with carbodiimide correlate with greater immunogenicity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}